NCT07123883

Brief Summary

This randomized controlled trial investigates the clinical effectiveness of dry needling in individuals with myofascial temporomandibular disorder (TMD). The study compares dry needling applied to trigger points in the masseter and temporalis muscles with conventional physical therapy. Primary outcomes include changes in pain intensity, and muscle EMG. Given these considerations, this study aims to investigate the clinical acute effectiveness of dry needling applied to the masseter and temporalis muscles in individuals diagnosed with myofascial TMD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 21, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

July 28, 2025

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 14, 2025

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
Last Updated

March 24, 2026

Status Verified

September 1, 2025

Enrollment Period

11 days

First QC Date

July 21, 2025

Last Update Submit

March 23, 2026

Conditions

Keywords

Dry needlingTemporomandibular DisordersMuscle Pain Dysfunction

Outcome Measures

Primary Outcomes (1)

  • Jaw pain intensity

    Jaw pain intensity was evaluated at the end of the range of motion using a 100 mm VAS, a tool recognized for its high reliability in musculoskeletal assessments. All participants were asked to indicate their pain level on the VAS, allowing for a subjective quantification of perceived pain intensity . Pain intensity was assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), with higher scores indicating worse outcomes.

    Baseline and After 10-minute

Secondary Outcomes (1)

  • Surface electromyographic (sEMG)

    Baseline and After 10-minute

Study Arms (2)

Dry Needling Group (DNG)

EXPERIMENTAL

In the DNG, under aseptic conditions, the needle was inserted into the predetermined trigger point of the masseter muscle using a guide tube. It was then advanced deeply into the muscle tissue and manipulated using a pistoning technique involving approximately ten in-and-out movements without complete withdrawal. The direction of the needle was systematically varied to stimulate adjacent regions of the muscle, maintaining an average insertion rate of one movement per second. Local twitch responses (LTRs) were elicited and monitored throughout the procedure. Upon completion, the needle was withdrawn, and gentle pressure was applied to the insertion site with a sterile cotton pad to prevent bleeding

Procedure: Dry Needling

Sham Group (SG)

SHAM COMPARATOR

In the SG, a validated sham needling procedure was simulated. Participants were positioned identically to the DNG and the same type of needle and guide tube were used. However, the safety lock on the needle was left intact, preventing skin penetration. A cotton pad was applied with light pressure to the skin surface, mimicking the procedure used in the DNG. This approach has been previously validated as a reliable sham control in dry needling research

Other: sham needling

Interventions

Dry NeedlingPROCEDURE

Dry Needling

Dry Needling Group (DNG)

In the SG, a validated sham needling procedure was simulated.

Sham Group (SG)

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients aged between 18 and 45 years presenting with complaints of jaw pain to the Department of Dentistry at A University.
  • Diagnosed with myofascial pain associated with temporomandibular dysfunction by a dentist, based on the Axis I criteria of the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD).
  • Jaw pain persisting for at least three months.
  • Pain elicited upon palpation of the masseter and/or temporalis muscles.
  • Presence of clicking or crepitus in the temporomandibular joint during mandibular movements.

You may not qualify if:

  • History of any confirmed or suspected inflammatory or neurological condition.
  • Presence of any oral or dental infection.
  • Any cognitive or communication impairment affecting data collection.
  • History of head or facial trauma.
  • Allergy to metals.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of Dentistry, Atlas University

Istanbul, Istanbul, 34403, Turkey (Türkiye)

Location

Istanbul Atlas University, Faculty of Dentistry

Istanbul, Kagithane, 34403, Turkey (Türkiye)

Location

MeSH Terms

Conditions

SpasmTemporomandibular Joint Disorders

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCraniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: All participants in the study were randomly assigned to one of two groups: the dry needling group (DNG) or the sham needling group (SG). In the DNG, deep dry needling was administered to the most sensitive myofascial trigger point identified in either the masseter or anterior temporalis muscle using a sterile acupuncture needle (0.20 × 13 mm, Qinzhou, China). The procedure was performed by a physiotherapist with seven years of clinical experience, under the supervision of a licensed physician.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2025

First Posted

August 14, 2025

Study Start

July 28, 2025

Primary Completion

August 8, 2025

Study Completion

August 30, 2025

Last Updated

March 24, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

The individual participant data will not be shared due to privacy and confidentiality concerns and because data sharing is not required for the objectives of this study.

Locations